Furthermore, Kaplan‐Meier analysis indicated that a higher ELK4 expression level was associated with poorer overall survival (OS) and disease‐free survival (DFS) in patients with CRC (Figure 7E). The gene discussed is ELK4; the disease is colorectal carcinoma.